AlphaMadera's AlphaVal page computes Akso Health Group's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag AHG as undervalued, fairly valued, or overvalued.

What is Akso Health Group's fair value?

Fair value for AHG is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value AHG?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from AHG's most recent reported fundamentals.

AHG - Akso Health Group

Price: -- --

AlphaVal

Deterministic, archetype-aware fair value

AlphaVal Unavailable

AlphaVal: AHG has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.